Incyte Corporation
INCY
$59.61
-$2.50-4.03%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -10.67% | 3.59% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -10.67% | 3.59% | |||
| Cost of Revenue | 20.48% | -40.35% | |||
| Gross Profit | -26.27% | 64.08% | |||
| SG&A Expenses | -0.16% | 5.52% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -5.07% | -9.06% | |||
| Operating Income | -27.19% | 75.46% | |||
| Income Before Tax | -25.35% | 100.43% | |||
| Income Tax Expenses | -32.46% | 124.72% | |||
| Earnings from Continuing Operations | -21.37% | 89.01% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -21.37% | 89.01% | |||
| EBIT | -27.19% | 75.46% | |||
| EBITDA | -26.28% | 68.77% | |||
| EPS Basic | -21.60% | 88.51% | |||
| Normalized Basic EPS | -22.97% | 65.36% | |||
| EPS Diluted | -21.42% | 88.54% | |||
| Normalized Diluted EPS | -23.05% | 64.46% | |||
| Average Basic Shares Outstanding | 0.29% | 0.27% | |||
| Average Diluted Shares Outstanding | 0.39% | 0.81% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||